Parsons Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,780
| Closed | -$536K | – | 347 |
|
|
2018
Q4 | $536K | Buy |
1,780
+56
| +3% | +$16.9K | 0.07% | 225 |
|
|
2018
Q3 | $609K | Sell |
1,724
-124
| -7% | -$43.8K | 0.06% | 234 |
|
|
2018
Q2 | $536K | Buy |
1,848
+60
| +3% | +$17.4K | 0.06% | 244 |
|
|
2018
Q1 | $490K | Buy |
1,788
+15
| +0.8% | +$4.11K | 0.06% | 256 |
|
|
2017
Q4 | $565K | Buy |
1,773
+46
| +3% | +$14.7K | 0.06% | 246 |
|
|
2017
Q3 | $541K | Buy |
1,727
+84
| +5% | +$26.3K | 0.06% | 237 |
|
|
2017
Q2 | $446K | Buy |
1,643
+180
| +12% | +$48.9K | 0.05% | 255 |
|
|
2017
Q1 | $400K | Buy |
1,463
+595
| +69% | +$163K | 0.05% | 260 |
|
|
2016
Q4 | $246K | Hold |
868
| – | – | 0.03% | 298 |
|
|
2016
Q3 | $272K | Sell |
868
-82
| -9% | -$25.7K | 0.04% | 282 |
|
|
2016
Q2 | $230K | Buy |
+950
| New | +$230K | 0.03% | 296 |
|
|
2015
Q2 | – | Sell |
-107
| Closed | -$45K | – | 363 |
|
|
2015
Q1 | $45K | Buy |
+107
| New | +$45K | 0.01% | 484 |
|